Iain Ross appointed as Executive Chairman, CEO steps down
03 January 2023: ReNeuron Group plc (AIM: RENE), a UK-based leader in stem cell-derived exosome technologies, announces that Catherine Isted, ACMA, Chief Executive Officer (“CEO”) has stepped down from her role with immediate effect.
Iain Ross, who has been on the Board since July 2021, has been appointed as Executive Chairman and will lead a restructuring of the business, with further announcements to be made in due course.